Analysts Are Bullish on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), Health Catalyst (HCAT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Day One Biopharmaceuticals (DAWN – Research ...
abrdn plc Buys New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 484,666 shares of the biopharmaceutical company’s stock ...
Catalyst Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
The stock's fall snapped a three-day winning streak.
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Shares of Catalyst Pharmaceuticals Inc. CPRX rose 1.34% to $23.40 Wednesday, on what proved to be an all-around favorable ...
Baird starts Catalyst Pharma with Outperform, $28 target
Baird initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ:CPRX) with an Outperform rating and set a price target ...
Fintel on MSN7d
Baird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform Recommendation
Fintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a ...
Catalyst Pharmaceuticals initiated with an Outperform at Baird
Baird analyst Joel Beatty last night initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target ...
stocknews8d
3 Niche Healthcare Stocks Tackling Rare Diseases
The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...
Investing17d
Catalyst Pharmaceuticals board member to retire
Coral Gables, FL-based Catalyst Pharmaceuticals , Inc. (NASDAQ:CPRX), a $2.69 billion market cap biopharmaceutical company that has delivered an impressive 54% return to shareholders over the past ...